- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00259207
Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract
29. september 2009 opdateret af: Assistance Publique - Hôpitaux de Paris
Pulmonary Valve Replacement : Study of Comparison Between a Standard Surgical Approach With Extracorporeal Circulation and an Off-pump Hybrid Strategy.
The purpose of this study is to compare 2 techniques of pulmonary valve replacement in patients with a large right ventricular outflow tract: a standard surgical treatment using cardiopulmonary bypass versus a medico-surgical hybrid strategy without extracorporeal circulation.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Pulmonary regurgitation is a common complication late after complete correction of a tetralogy of Fallot.
It progressively leads to a right ventricular dilatation that has been strongly associated with ventricular arrhythmia, sudden death and right ventricular insufficiency.
Pulmonary valve replacement reduces the rate of complications but the precise timing for this procedure remains unknown.
Moreover, pulmonary valve replacement, even before the occurrence of symptoms, doesn't allow for a total recovery in all patients.
Reasons are not known, but cardiopulmonary bypass as well as late referral to surgery have been incriminated to explain the persistence of right ventricular dysfunction after surgical valvular.
Therefore, a strategy avoiding cardiopulmonary bypass could potentially preserve the right ventricular function and in the meantime reduce the hospitalisation length and morbid-mortality.
For the last six years, we and others have developed a technique of percutaneous pulmonary valve implantation.
Encouraging results were reported in the treatment of failing right ventricular to pulmonary artery conduit, but presents indications are limited and the innovative technique could not be offered to most of patients requiring pulmonary valve replacement.
In particular, to date, conventional surgery is the only approach for patients with large pulmonary trunk over 22 mm in diameter.
We had the idea of collaborating with the surgeons to try to improve the outcome of valvular in these patients.
We would like to investigate a hybrid strategy in those patients with large right ventricular outflow tract inaccessible to solely transcatheter technique.
The studied technique will associate a surgical pulmonary artery banding without cardiopulmonary bypass immediately followed by a transventricular or a transvenous pulmonary valve insertion using a conventional valved stent.
The purpose of this randomized study is to evaluate benefits and risks of the medico-surgical hybrid strategy, and to compare both strategies hybrid approach and conventional surgery with extracorporeal circulation in term of right ventricular function recovery.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
8
Fase
- Fase 3
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Paris, Frankrig, 75015
- NECKER HOSPITAL for Sick Children, 149 R. de SEVRES
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
6 år til 90 år (Barn, Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Patient with surgical indication of pulmonary valve replacement for significant pulmonary regurgitation
- Pulmonary trunk diameter > 22mm
- Age > 5 years old or weight > 20kg
- Acceptance of protocol
- Social regimen security
Exclusion Criteria:
- No indication of pulmonary valve replacement
- Age < 5 years old or weight < 20kg
- Extra-cardiac disease with a vital prognosis under 6 months
- Heparin and contrast allergy
- Clinical or biological signs of infection
- Pregnancy
- Patients in emergency state
- Patients included in an another research protocol during the last months
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: classic surgery
|
Pulmonary valve insertion
|
|
Eksperimentel: medical surgery hybride
|
medical surgery hybride
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Right ventricular function
Tidsramme: during the study
|
during the study
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Morbidity and mortality
Tidsramme: during the study
|
during the study
|
|
Length of stay
Tidsramme: during the study
|
during the study
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Younes BOUDJEMLINE, MD,PhD, Assistance Publique - Hôpitaux de Paris
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. december 2005
Primær færdiggørelse (Faktiske)
1. maj 2009
Studieafslutning (Faktiske)
1. maj 2009
Datoer for studieregistrering
Først indsendt
28. november 2005
Først indsendt, der opfyldte QC-kriterier
28. november 2005
Først opslået (Skøn)
29. november 2005
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
30. september 2009
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
29. september 2009
Sidst verificeret
1. marts 2007
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- P040413
- AOR04068
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .